HCPCS code J9292 — Inj, pemetrexed dipotassium. Status: Active. Effective Jul 1, 2025. Source: CMS HCPCS Level II.

J9292

Active

Inj, pemetrexed dipotassium

Injection, pemetrexed dipotassium, 10 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Jul 1, 2025
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 2076

MUE — Medically Unlikely Edits

Maximum units of J9292 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
DME Supplier 150
Outpatient Hospital 150
Practitioner Services 150

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
83831-0131-01 AXTLE
83831-0132-01 AXTLE

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • Revised 2025-Q3
    Inj, pemetrexed (avyxa) 10mg
    Inj, pemetrexed dipotassium
  • New Code 2025-Q3
    Inj, pemetrexed dipotassium